FDA — authorised 22 October 2021
- Application: BLA761197
- Marketing authorisation holder: GENENTECH INC
- Local brand name: SUSVIMO
- Indication: SOLUTION — INJECTION
- Status: approved
🇺🇸 GNR-067 in United States
FDA authorised GNR-067 on 22 October 2021
Marketing authorisation
Other Diabetes approved in United States
Frequently asked questions
Is GNR-067 approved in United States?
Yes. FDA authorised it on 22 October 2021.
Who is the marketing authorisation holder for GNR-067 in United States?
GENENTECH INC holds the US marketing authorisation.